These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 26206516)

  • 21. Correlation of currently used radiobiological parameters with local control and acute and late mucosal toxicity in randomised studies of altered fractionation for locally advanced head and neck cancer.
    Hartley A; Sanghera P; Kazi W; Mehanna H; McConkey C; Glaholm J; Fowler J
    Clin Oncol (R Coll Radiol); 2011 Feb; 23(1):29-33. PubMed ID: 20829006
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered fractionation radiotherapy in head and neck cancer: clinical issues and pitfalls of "evidence-based medicine".
    Antognoni P; Corvò R; Zerini D; Orecchia R
    Tumori; 2005; 91(1):30-9. PubMed ID: 15850002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The management of interruptions to radiotherapy in head and neck cancer: an audit of the effectiveness of national guidelines.
    James ND; Williams MV; Summers ET; Jones K; Cottier B;
    Clin Oncol (R Coll Radiol); 2008 Oct; 20(8):599-605. PubMed ID: 18555671
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Altered fractionation in radiotherapy for head and neck cancer: too early to close the race and announce the winner?
    Bentzen SM; Dische S
    Radiother Oncol; 1999 May; 51(2):105-7. PubMed ID: 10435799
    [No Abstract]   [Full Text] [Related]  

  • 25. Hyperfractionated accelerated radiotherapy alone and with concomitant chemotherapy to the head and neck: treated within and outside of randomized clinical trials.
    Hehr T; Classen J; Schreck U; Glocker S; Bamberg M; Budach W
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1424-30. PubMed ID: 15050319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Confirmation of improved local-regional control with altered fractionation in head and neck cancer.
    Fowler JF; Harari PM
    Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):3-6. PubMed ID: 10924965
    [No Abstract]   [Full Text] [Related]  

  • 27. Evidence-based radiation oncology in head and neck squamous cell carcinoma.
    Corvò R
    Radiother Oncol; 2007 Oct; 85(1):156-70. PubMed ID: 17482300
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Importance of overall treatment time for the response to radiotherapy in patients with squamous cell carcinoma of the head and neck.
    Overgaard J; Alsner J; Eriksen J; Horsman MR; Grau C
    Rays; 2000; 25(3):313-9. PubMed ID: 11367896
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Continuous accelerated 7-days-a-week radiotherapy for head-and-neck cancer: long-term results of phase III clinical trial.
    Skladowski K; Maciejewski B; Golen M; Tarnawski R; Slosarek K; Suwinski R; Sygula M; Wygoda A
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):706-13. PubMed ID: 17011446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclin B1 overexpression and resistance to radiotherapy in head and neck squamous cell carcinoma.
    Hassan KA; Ang KK; El-Naggar AK; Story MD; Lee JI; Liu D; Hong WK; Mao L
    Cancer Res; 2002 Nov; 62(22):6414-7. PubMed ID: 12438226
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RTOG 0522: a randomized phase III trial of concurrent accelerated radiation and cisplatin versus concurrent accelerated radiation, cisplatin, and cetuximab [followed by surgery for selected patients] for Stage III and IV head and neck carcinomas.
    Clin Adv Hematol Oncol; 2007 Feb; 5(2):79-81. PubMed ID: 17344795
    [No Abstract]   [Full Text] [Related]  

  • 32. Quality control and quality assurance in HIV prevention research: model from a multisite HIV prevention trial. NIMH Multisite HIV Prevention Trial.
    AIDS; 1997 Dec; 11 Suppl 2():S49-53. PubMed ID: 9475711
    [No Abstract]   [Full Text] [Related]  

  • 33. Palliative radiation therapy for head and neck cancer: toward an optimal fractionation scheme.
    Chen AM; Vaughan A; Narayan S; Vijayakumar S
    Head Neck; 2008 Dec; 30(12):1586-91. PubMed ID: 18798313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Altered-fractionated radiotherapy in locally advanced head and neck cancer.
    Bernier J; Horiot JC
    Curr Opin Oncol; 2012 May; 24(3):223-8. PubMed ID: 22123237
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Benefits of chemotherapy in head and neck cancer.
    Brockstein B
    Lancet; 2000 Aug; 356(9231):767-8. PubMed ID: 11085713
    [No Abstract]   [Full Text] [Related]  

  • 36. A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck.
    Budach W; Hehr T; Budach V; Belka C; Dietz K
    BMC Cancer; 2006 Jan; 6():28. PubMed ID: 16448551
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiation-free weekend rescued! Continuous accelerated irradiation of 7-days per week is equal to accelerated fractionation with concomitant boost of 7 fractions in 5-days per week: report on phase 3 clinical trial in head-and-neck cancer patients.
    Skladowski K; Hutnik M; Wygoda A; Golen M; Pilecki B; Przeorek W; Rutkowski T; Lukaszczyk-Widel B; Heyda A; Suwinski R; Tarnawski R; Maciejewski B
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):741-6. PubMed ID: 22836063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reporting of time-to-event end points and tracking of failures in randomized trials of radiotherapy with or without any concomitant anticancer agent for locally advanced head and neck cancer.
    Le Tourneau C; Michiels S; Gan HK; Siu LL
    J Clin Oncol; 2009 Dec; 27(35):5965-71. PubMed ID: 19805677
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Quality of life for patients treated for head and neck carcinoma].
    Maingon P; Créhange G; Bonnetain F; Ligey-Bartolomeu A; Chamois J; Bruchon Y; Romanet P; Truc G
    Cancer Radiother; 2010 Oct; 14(6-7):526-9. PubMed ID: 20724192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RTOG 9003: the untold story.
    Feigenberg S; Patel K; Amdur RJ; Mendenhall WM
    Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):251-2. PubMed ID: 25304785
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.